Back to results
US 2026/0217689 A1Published application
Substituted 2-(Pyrrolidine-3-yl)acetic Acid Derivative, Preparation Method and Use Thereof
AssigneeInnovstone Therapeutics Limited
InventorsYunlong SONG, Wenqing XU, Yang YAO, Hongyan KOU, Linfeng HUANG, Zhiyuan CHEN, Kai LU, Disha WANG, Xiaolin ZHANG, Yongmei LIU
Life of this patent
Estimating the term…
Abstract
The invention provides a class of compounds represented by Formula (I), and pharmaceutically acceptable salts thereof. The compounds of the invention have strong inhibitory activity against Lp(a) assembly and can be used to treat cardiovascular diseases (CVDs).
Claims10
-19. (canceled)
A compound which is:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.